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ABSTRACT A small group of HIV-1-infected individuals, called long-term nonpro-
gressors (LTNPs), and in particular a subgroup of LTNPs, elite controllers (LTNP-ECs),
display permanent control of viral replication and lack of clinical progression. This
control is the result of a complex interaction of host, immune, and viral factors. We
identified, by phylogenetic analysis, a cluster of LTNP-ECs infected with very similar
low-replication HIV-1 viruses, suggesting the contribution of common viral features
to the clinical LTNP-EC phenotype. HIV-1 envelope (Env) glycoprotein mediates sig-
naling and promotes HIV-1 fusion, entry, and infection, being a key factor of viral fit-
ness in vitro, cytopathicity, and infection progression in vivo. Therefore, we isolated
full-length env genes from viruses of these patients and from chronically infected
control individuals. Functional characterization of the initial events of the viral infec-
tion showed that Envs from the LTNP-ECs were ineffective in the binding to CD4
and in the key triggering of actin/tubulin-cytoskeleton modifications compared to
Envs from chronic patients. The viral properties of the cluster viruses result in a de-
fective viral fusion, entry, and infection, and these properties were inherited by ev-
ery virus of the cluster. Therefore, inefficient HIV-1 Env functions and signaling de-
fects may contribute to the low viral replication capacity and transmissibility of the
cluster viruses, suggesting a direct role in the LTNP-EC phenotype of these individu-
als. These results highlight the important role of viral characteristics in the LTNP-EC
clinical phenotype. These Env viral properties were common to all the cluster viruses
and thus support the heritability of the viral characteristics.
IMPORTANCE HIV-1 long-term nonprogressor elite controller patients, due to their
permanent control of viral replication, have been the object of numerous studies to
identify the factors responsible for this clinical phenotype. In this work, we analyzed
the viral characteristics of the envelopes of viruses from a phylogenetic cluster of
LTNP-EC patients. These envelopes showed ineffective binding to CD4 and the sub-
sequent signaling activity to modify actin/tubulin cytoskeletons, which result in low
fusion and deficient entry and infection capacities. These Env viral characteristics
could explain the nonprogressor clinical phenotype of these patients. In addition,
these inefficient env viral properties were present in all viruses of the cluster, sup-
porting the heritability of the viral phenotype.
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Natural HIV-1 infection shows a wide range of disease outcomes that result in theclassification of patients according to progression time. A small group of HIV-1-
infected individuals, called long-term nonprogressors (LTNPs), and especially a sub-
group of LTNP elite controllers (LTNP-ECs), display permanent control of viral replica-
tion and lack of clinical progression. This control is the result of a complex interaction
of host, immune, and viral factors.
In HIV-1 patient classifications, LTNPs are individuals infected with HIV-1 for more
than 10 years, maintaining high CD4 lymphocyte numbers without clinical symptoms,
and remaining therapy naive (1). Within the LTNP group and according to HIV-1 plasma
viral load, we can distinguish LTNP noncontrollers (LTNP-NCs) with viral loads above
2,000 copies/ml, LTNP viremic controllers (LTNP-VCs) with viral loads between 50 and
2,000 copies/ml, and LTNP-ECs with undetectable viral loads (50 copies/ml) (2). The
latter definition has been used for the selection of the individuals of this study. Patients
with very similar characteristics are also called elite suppressors (3) or HIV-1 controllers
(HICs) (4). Progressor patients are individuals with a symptomatic infection or with
the initiation of antiretroviral therapy (ART) within 10 years after seroconversion
and a minimum of 3 determinations above 2,000 copies/ml (2). Different nomen-
clatures have been used to name HIV-1 patients by distinct groups, and these
definitions are reviewed in reference 5.
The LTNP phenotype has been associated with host genetic background, principally
HLA-B genotypes—mostly HLA-B57/B58 or -B27 (6) and HLA-C (2). Immunologic studies
demonstrated potent and broad cytotoxic T lymphocyte (CTL) responses in LTNPs (7).
In addition, viral factors were also identified in groups of LTNPs, like viruses with
important deletions in the nef gene in a cohort of Australian nonprogressors (8) or with
mutations in different genes (9). In general, viruses with low replication capacity are
detected in LTNPs (10–13).
Plasma viral load in infected individuals was found to be a good predictor of
progression to AIDS (14), and the set point viral load (SPVL), or the stable quantity of
the virus in the patient’s blood after primary infection, has been directly correlated with
infectiousness and virulence (15). SPVL in HIV-1 patients ranges over several orders of
magnitude and is a key determinant of disease progression. A number of recent studies
reported the high heritability of the SPVL, implying that viral genetic factors contribute
substantially to the overall variation in viral load. From a virological point of view,
“heritability” is the fraction of variability in disease outcome explained by pathogen
genetics, because these factors are “inherited” by the new host upon infection (16). In
transmission pair studies, viral properties and fitness were inherited in the recipients,
as shown by the similarity of viral loads in linked individuals (17–20). Viral heritability
has also been inferred by phylogenetic approaches (17), but discordant values were
obtained in different studies from distinct locations ranging from 6 to 59% (16), raising
the question of how effectively HIV-1 phylogenies can be used to measure heritability
(21). A modeling approach by Bonhoeffer et al. demonstrated that high heritability is
the most parsimonious explanation for the observed variance of SPVL (22). In a
standardized study with 2,028 samples from different European countries, viral genetic
variation accounts for a third of variability in HIV-1 SPVL in Europe (16). Most of the
research on heritability in HIV-1 has either focused on transmission pairs or on phylo-
genetic signal in large cohorts of patients. Although it could bridge the gap between
these two extremes, heritability in HIV-1 transmission clusters has to our knowledge not
been demonstrated so far.
It has been reported that HIV-1 envelope glycoprotein (Env) functions, such as
tropism or fusogenicity are linked to in vitro HIV-1 cytopathicity (23, 24) and viral fitness
(25, 26), as well as to clinical progression of HIV-1 infection (27) and simian immuno-
deficiency virus (SIV) infection in vivo (28). Moreover, we and other groups have
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previously reported that HIV-1 Env-gp120-induced posttransduction modifications and
reorganization of tubulin and actin cortical cytoskeleton are key signals and processes
to promote efficient early HIV-1 infection (29–34). These Env/CD4-mediated events
increase the probability of HIV-1 Env-CD4/coreceptor interactions, potentiating fusion
pore formation, and thus HIV-1 entry and infection. Therefore, it is plausible to propose
that HIV-1 Env-mediated early functions could be responsible for an inefficient HIV-1
infection and viral progression in vivo, being determinant for the LTNP-EC clinical
phenotype in some HIV-1 individuals.
In a previous study, we identified within a large group of Spanish HIV-1 LTNP
patients a cluster of 5 patients with an LTNP-EC clinical phenotype (see Fig. 1A). These
individuals were infected for more than 25 years with very similar viruses, all showing
low replication characteristics and 11 unusual amino acid changes in the envelope
protein of the viruses and linked by clinical characteristics, risk practices, and epide-
miological characteristics, identifying a transmission cluster (35).
For these reasons, in this work, we performed a comprehensive functional charac-
terization of Envs from these LTNP-EC viruses, focusing on the initial events of viral
infection: binding of Env to CD4 cells, Env-triggered early signals for actin and
-tubulin cytoskeleton modulation, and the subsequent membrane fusion and early
infection in target cells. We observed that the genotypic and phenotypic characteristics
of the Env proteins from the HIV-1 viruses of the LTNP-EC cluster were inherited by all
the patients’ viruses and produced, in individuals with different host genotypes, the
same clinical LTNP-EC phenotype.
RESULTS
Low replication and transmission of the viruses from the LTNP cluster. In a
previous study, we described a cluster of 6 HIV-1 individuals, 5 of them with known
LTNP characteristics, using a Bayesian phylogenetic reconstruction from complete env
gene sequences; this cluster was supported by a posterior probability of 0.87, and it
increased to 0.98 when patient LTNP_RF_15 was not included (35) (Fig. 1A). The mean
genetic distance among the cluster viruses was 0.72%, and the mean genetic distance
to the cluster’s most recent common ancestor (MRCA) was 0.96%.
The env gene nucleotide sequences from these patients (35) displayed very short
branches in the phylogenetic tree, indicating limited viral replication, in comparison
with other LTNP patients from Spain or old viruses from Europe and North America
(Fig. 1A). When we calculated the mean divergence of all the env gene sequences
studied from the subtype B most recent common ancestor (MRCA) of the tree, samples
from the cluster individuals, although obtained in 2004 and 2005, showed a divergence
of 4.86% substitutions per nucleotide (S/N) (Fig. 1B). In contrast, old chronic progressor
HIV-1 individuals, sampled before 1995, displayed a divergence of 13.73% S/N, and
Spanish samples, obtained between 1998 and 2005, showed a divergence of 15.16%
S/N (Fig. 1B). Genetic distance from each nucleotide sequence was calculated as the
MRCA-to-tip distances from a MrBayes phylogenetic tree using TreeStat v.1.2 (35).
Because of the low fidelity of the reverse transcriptase, HIV-1 replication is inevitably
linked to the generation of variability (36). In phylogenetic reconstructions, the accu-
mulation of variability results in a progressive increase of the genetic divergence from
MRCA, visualized by the branch length (37–39). The very short branch length and the
limited divergence of the sequences from the cluster viruses (Fig. 1B) led us to conclude
that these viruses went through a comparatively very limited number of replication
cycles. This result is even more relevant considering that samples were taken at least
15 years after primary infection (Table 1) and pointed to a potential functional defect
in the viruses from the LTNP HIV-1 individuals that could impair replication capacity and
transmissibility.
Functional analysis of Env from HIV-1 viruses from the LTNP-EC cluster. To
investigate the causes of the limited viral replication and the restricted env sequence
evolution in the cluster HIV-1 viruses, we studied the phenotypic characteristics of viral
Env from the patients. The nucleotide sequences of three of the cluster patients
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FIG 1 Phylogenetic and genetic distance analyses of the sequences from the cluster viruses to the MRCA. (A) Phylogenetic tree with
complete env sequences from the Bayesian Markov chain Monte Carlo (MCMC) analysis (MrBayes). The 50% majority rule consensus
obtained by Bayesian MCMC analysis is shown, and the most recent common ancestor (MRCA), including the vast of majority
sequences analyzed, is marked (solid diamond). Branch lengths represent the mean value observed for that branch among the
postburning sampled trees. The symbols identify nucleotide sequences analyzed: solid circles correspond to old sequences collected
before 1995, and solid triangles correspond to Spanish sequences collected from 1989 to 2005. Only the Spanish cluster sequences
collected between 2004 and 2005 are identified by name. Gray lines are subtype D sequences used as an outgroup. (B) Genetic
distance of the sequences to the MRCA. MRCA genetic distances of the cluster LTNP-EC viruses studied were compared with the
MRCA genetic distances of viruses obtained from HIV-1-infected individuals before 1995 (old samples) or from Spanish HIV-1-
infected individuals taken from 1989 to 2005 (35). Genetic distance was calculated as the MRCA-to-tip distances from the MrBayes
phylogenetic tree using TreeStat v.1.2 (http://tree.bio.ed.ac.uk/software/treestat/). Boxes represent the 25 to 75% of the mean, and
the whiskers indicate 5 and 95%. The panel shows P values for nonparametric Dunn’s test for multiple comparisons. (C) Maximum
likelihood phylogenetic trees of patients’ viral sequences in the env gene. Shown are partial HIV-1 PBMC-derived gp120 env
sequences of cluster patients LTNP_1 (black circles), LTNP_3 (green circles), LTNP_5 (red circles), LTNP_RF_15 (brown circles),
LTNP_RF_21 (pink circles), and AS7 (blue circles) and progressor patients I_10 (gray triangles), I_14 (teal triangles), IV_10 (purple
triangles), and RIS_06 (turquoise triangles). The clones analyzed are indicated by open symbols and arrows. Asterisks indicate
nonfunctional clones. Numbers at branch nodes refer to the bootstrap support. (Only values greater than 70% are shown.) Branch
lengths are drawn to scale.
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(LTNP_1, LTNP_3, and LTNP_5) have been extensively investigated in the laboratory
during a follow-up of at least 7 years (13, 40). In these studies, we detected a limited
evolution of the sequences, but different viral subpopulations were identified in the
tree, particularly in patients LTNP_1 and LTNP_5 (Fig. 1C). For the functional analysis of
the viral Envs, we selected 4 clones in patient LTNP_1 (Fig. 1C) and 3 clones in patient
LTNP_3 (Fig. 1C) corresponding to the different lineages found in these patients.
Patient LTNP_5 also showed a tree with distinct lineages but all the recovered clones
were nonfunctional (Fig. 1C, asterisks). For patient AS7, the sole patient without clinical
data and follow-up, we only obtained a sample in 1989 and given the low diversity
found in the quasispecies of this sample, a single clone was selected (Fig. 1C). For
patients LTNP_RF_15 and LTNP_RF_21, we only had one clone from each patient.
The clones from the progressor patients were obtained from Spanish HIV-1 patients
without follow-up, and we have no information on the heterogeneity of the quasispe-
cies, although the trees showed long tip branches. The clones analyzed from each
patient are marked in Fig. 1C with arrows, and when possible, we included at least two
clones from each control patient.
To determine whether the Envs, isolated from HIV-1 viral particles of different
individuals, are responsible for the poor ability of these viruses to replicate, we first
expressed Envs isolated from primary LTNP-EC and chronic progressor viruses in 293T
cells, in order to analyze their cell surface expression. Transfected cells stained with
monoclonal antibody (MAb) 2G12 showed a median value of the Env expression from
the LTNP-EC viruses not statistically different from the chronic progressor viruses and
comparable to reference Envs (Fig. 2A). Therefore, the inefficacy of HIV-1 viruses from
LTNP-EC individuals to replicate cannot be attributed to a difference in the Env
expression level at the cell surface of cells producing virions. To further investigate this,
HIV-1 luciferase-reporter pseudoviruses were produced using a pNL4.3-Luc-R-E vector,
and each of the different env expression clones: 8 from 3 of the cluster viruses, 6 from 4
chronic progressors, and 2 from reference strains SF_162 (R5-tropic strain) and
89ES_061 (X4-tropic strain). All the env nucleotide sequences from the LTNP-EC clus-
ter HIV-1 viruses showed an R5 tropism (Web PSSM; https://indra.mullins.microbiol
.washington.edu/webpssm). This technical approach, using the same viral backbone
with different env genes, allowed the generation of viral particles to infect the same
permissive cells for the analysis of the functional involvement of each viral Env in
infection. Equal amounts of luciferase reporter pseudoviruses were used to infect
CEM.NKR-CCR5 cells, providing a quantification of HIV-1 entry in the absence of other
viral factors and of any influence of late steps of viral infection (29, 30, 41). We observed
that, in comparison with control and chronic progressor-derived viruses, LTNP-EC
cluster-derived pseudoviruses poorly infected cells (P  0.0002) (Fig. 2B). Thus, the Envs
from these LTNP-EC HIV-1 viruses were unable to promote efficiently the early steps of
viral infection.
Having ruled out a defect in Env expression, we further evaluated the biological
functions of these cell-surface-expressed Envs in promoting cell-to-cell HIV-1 viral
TABLE 1 Epidemiological, clinical, and host characteristics of the patients











LTNP_1 F Madrid C. S. Sandoval IDU 1990 2005 LTNP-VCs 125 628 B1501/B2705
LTNP_3 M Madrid C. S. Sandoval IDU 1988 2005 LTNP-ECs 50 880 B2705/B5801
LTNP_5 M Madrid C. S. Sandoval IDU 1986 2005 LTNP-ECs 50 559 B2705/B3503
LTNP_RF_15 M Madrid 12 de Octubre IDU 1989 2004 LTNP-ECs 50 460 B44/B57
LTNP_RF_21 M Madrid 12 de Octubre IDU 1985 2004 LTNP-ECs 50 690 B47/B14
AS7 F NKb El Patriarca IDU 1989 1989 NK NK NK B3501/B5101
I_10 F Madrid C. S. Sandoval IDU/HT NK 1993 Progressors 8.9  104 251
IV_10 M Vigo IDU 1991 1994 Progressors 1.7  106 342
I_14 F Madrid C. S. Sandoval IDU/HT 1987 1994 Progressors 1.3  105 337
RIS_06 M Madrid C. S. Sandoval MSM 2005 2005 Progressors 7.6  104 436
aTransmission route: IDU, intravenous drug user; MSM, men who have sex with men; HT, heterosexual.
bNK, not known.
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transfer and infection. This process mainly relies in the first HIV-1 Env-CD4 interaction
and signaling, which are key for pore fusion formation and productive viral infection
(29, 30, 32, 33, 42, 43). To analyze the interaction with CD4, we first employed a viral
transfer assay using unstimulated primary CD4 T cells as target cells (Materials and
Methods) (Fig. 3A).
In this assay, we forced the formation of virological synapses between Env- and
Gag-expressing 293T cells and freshly purified primary CD4 T cells. Hence, synapse
formation allows budding viruses to rapidly attach to CD4 T cells by a mechanism that
is strictly dependent on the binding of gp120 expressed on 293T cells to the CD4
molecule on target cells (Fig. 3A). The subsequent transfer of budding particles from
293T cells to CD4 T cells is independent of the coreceptor interaction or the gp41
activation (43). To fully characterize our experimental model, we used the reference
Envs BaL (CCR5 tropism) and NL4.3 (CXCR4 tropism). Pharmacological inhibition with
molecules that block fusion at different stages of Env function showed a complete
blockade of HIV-1 binding when interfering with the gp120-CD4 interaction (with the
FIG 2 Analysis of the expression and viral entry efficiency of the different HIV-1 Env proteins from
LTNP-EC and control patients. (A) Flow cytometry analysis of the cell-surface expression level of the
assayed HIV-1 Envs in 293T cells. (B) Luciferase-based assay of viral entry and infection in permissive
CEM.NKR-CCR5 cells by nonreplicative HIV-1 luciferase reporter pseudoviruses bearing viral Envs from
cluster LTNP-ECs (dark gray bars) or progressors (light gray bars). SF162 and 89ES_061 are reference
strains (black bars). All data were corrected by the nonproductive infection values (baseline) obtained
with a neutralizing anti-CD4 MAb (5 g/ml), under the same experimental conditions. Data are values
from 10 independent experiments carried out in triplicate and comparing median values between
groups (nonparametric Mann-Whitney test). a.u., arbitrary light units.
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FIG 3 Analysis of HIV-1 Env-mediated cell-to-cell viral transfer. (A) An outline of the experimental model used for the analysis of Env-mediated cell-to-cell fusion
and viral transfer is shown. Briefly, 293T cells were cotransfected with env and a Δenv HIV-1 expression plasmid. After 24 h, effector cells producing HIV-1
particles were cocultured with primary CD4 T cells to force synapsis formation and massive binding of budding particles to target cells. Env expression and
(Continued on next page)
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anti-CD4 antibody Leu3A) and no effect by coreceptor fusion or postfusion blockade
(CCR5 or CXCR4 antagonists TAK779 or AMD3100, gp41 inhibitor C34, or reverse
transcription inhibitor zidovudine [AZT]) (Fig. 3B). Further, we used different available
NL4.3 mutant derivatives that abrogate either CD4 binding capacity (the D368R mu-
tation in gp120 [44]) or fusion capacity (the 41.2 mutation in gp41 [24]). These
mutations do not alter Env expression in transfected cells (Fig. 3C). Consistent with
pharmacological data, the D368R mutant completely blocked viral binding to CD4 T
cells, while the 41.2 mutant had no significant effect (Fig. 3D).
These data demonstrated that the assay can assess the Env-CD4 interaction, and it
was therefore employed to quantify the ability of mediating CD4 binding for reference
as well as Envs isolated from the LTNP-ECs and chronic progressors (Fig. 3B and E).
The Envs from the HIV-1 LTNP-ECs displayed a significantly lower ability (P  0.0001)
to transfer viral particles to primary CD4 T cells than Envs from chronic progressor
HIV-1 individuals (Fig. 3E), suggesting that the Envs from LTNP-EC viruses had
impaired binding to the cell-surface-expressed CD4 molecule.
In addition, the fusion capacity of the same env clones was analyzed in cocultures
between 293T transfected cells and TZM-bl cells. Consistent with pseudovirus infectiv-
ity (Fig. 2B), this assay yielded significantly lower fusion values for Envs from LTNP-EC
HIV-1 viruses compared to those from chronic progressors’ HIV-1 viruses (P  0.0001)
(Fig. 4A). Thus, the phenotypic characterization of the Envs from the LTNP-EC cluster
confirmed that the low replication capacity detected for the HIV-1 viruses in the cluster
was associated with impaired Env function, thereby showing a significant lower fuso-
genic capacity than viruses in chronic progressors (Fig. 4A). In addition, a significant
correlation was observed between the HIV-1 transfer data, mediated by Env/CD4
binding capacity and fusogenicity (r  0.635, P  0.0171, Spearman’s test) (Fig. 4B),
thus linking the fusion defect to a low CD4 affinity. Furthermore, a fusogenicity index
(FI) was calculated for each Env clone. The FI normalizes fusion values to Env expression
and showed lower values in Env clones isolated from the LTNP cluster compared to
progressors (Fig. 4C). Taken together, these data further confirm the deficient Env
fusion capacity observed in the cluster LTNP envelopes.
Signaling activity of Envs from the cluster HIV-1 viruses. We next compared the
signaling ability of Envs from LTNP-EC and chronic progressor HIV-1 viruses in permis-
sive CEM.NKR-CCR5 cells, during the early virus-cell contacts in infection, by measuring
the stabilization of acetylated -tubulin. Consistent with the significantly impaired
HIV-1 entry and infection promoted by LTNP-ECs’ Envs and their low CD4 binding
(Fig. 2B and 3E, respectively), the Envs from LTNP-ECs promoted acetylation of
-tubulin to a smaller extent than the Env from the BaL.01 viral strain (Fig. 5A). On the
contrary, viruses bearing chronic progressors’ Envs triggered acetylation of -tubulin as
efficiently as the BaL.01 Env and with a statistically higher activity than Envs from
LTNP-EC HIV-1 viruses (Fig. 5A). Moreover, it has been described that efficient HIV-1
infection is achieved only when Env-triggered signals are strong enough to induce
pseudopod formation by promoting actin cytoskeleton reorganization and capping in
at least 20 to 30% of the cells (29, 30, 33). In an experimental model analyzed by
FIG 3 Legend (Continued)
HIV-1 binding were analyzed by flow cytometry using anti-Env and anti-p24 antibodies, respectively. (B) HIV-1 transfer to primary CD4 T cells induced by the
CCR5-using Env from BaL.01 or the CXCR4-using Env from NL4.3. Cocultures were performed in the presence of the following inhibitors: 1 g/ml of the anti-CD4
antibody Leu3A or 10 g/ml of the CCR5 antagonist TAK779 or the CXCR4 antagonist AMD3100, the fusion inhibitor peptide C34, and the reverse transcriptase
inhibitor AZT. The dotted line corresponds to background levels of signal obtained in cocultures of CD4 T cells and 293T cells transfected with the Δenv
plasmid PSG3. Data are means  standard deviations (SD) from two different experiments. (C) Expression of HIV-1 Env in cells untransfected (control [black line]),
transfected with the Δenv plasmid (PSG3 [green line]), or cotransfected with this plasmid and the indicated env from NL4.3 (blue line), the D368R mutant (red
line), or the 41.2 mutant (purple line). (D) HIV-1 transfer (bound virus) to CD4 T cells assessed by flow cytometry after coculture with 293T cells expressing
Env from NL4.3 (black bars), the D368R mutant (gray bars), or the 41.2 mutant (open bars) and CD4 T cells. Cocultures were performed in the presence of
inhibitors as in panel B; the anti-gp120 antibody that blocks the CD4 binding site IgGb12 was used at 10 g/ml. The dotted line corresponds to background
levels of signal obtained in cocultures of CD4 T cells and 293T cells transfected with the Δenv plasmid PSG3. Data are means  SD from three different
experiments. (E) Analysis of the ability to induce cell-to-cell virus transfer of HIV-1 Env proteins obtained from cluster LTNP-ECs (dark gray bars) or progressors
(light gray bars) or reference strains (SF162, NL4.3, BaL.01, and 89ES_061 [black bars]). Data are from three independent experiments, comparing mean values
between groups. (P values compare medians between groups using a nonparametric Mann-Whitney test.)
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FIG 4 Analysis of HIV-1 Env fusogenic activity. (A) Analysis of the ability to induce cell-to-cell fusion of
HIV-1 Env proteins obtained from cluster LTNP-EC (dark gray bars), progressor individuals (light gray
bars), or reference HIV-1 viral strains (SF162, NL4.3, BaL.01, and 89ES_061 [black bars]). Data are from
three independent experiments, comparing mean values between groups (nonparametric Mann-
Whitney test). (B) Spearman’s nonparametric correlation between HIV-1 transfer activity after cell-to-cell
contact (a surrogate marker of binding of the Env protein to the CD4 molecule) and the fusion capacity
of the Envs obtained from the LTNP-EC cluster viruses are shown. Mean values of the three independent
experiments for each Env were used for the correlation analysis. (C) A fusogenicity index (FI) was
calculated for each Env clone as the ratio of fusion activity and relative fluorescence intensity. Values for
LTNPs, progressors, and reference Env clones are shown: n  8, 6, and 4, respectively. Boxes represent
medians and interquartile ranges of values.
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FIG 5 Effect of HIV-1 Env on -tubulin acetylation and F-actin and acetylated -tubulin reorganization, capping, and pseudopodium
formation. (A, left panel) Quantitative Western blot analysis of LTNP-EC HIV-1 Env-induced -tubulin acetylation in permissive cells
compared with Envs from reference and chronic progressor (CP) patients’ viral strains, represented as acetylated -tubulin in reference
to total -tubulin (Ac. -tub/-tub ratios). A representative experiment of six performed is shown. (Right panel) Histograms show the
quantification of HIV-1 Env-mediated -tubulin acetylation in permissive cells from six independent experiments carried out in triplicate.
Data are means  standard errors of the means (SEM). Acetylated -tubulin/-tubulin ratios are given in arbitrary light units (a.u.). (B) A
series of fluorescent confocal images shows HIV-1 Env-induced redistribution of acetylated -tubulin and actin cytoskeleton and
pseudopodium formation in control, untreated, or HIV-1 Env early infected permissive cells. Merged images are shown with DAPI
(4=,6-diamidino-2-phenylindole) labeling of the nucleus. A representative experiment of six performed is shown indicating the percentage
of cells affected per 150 cells counted under any experimental condition. P values from Student’s t test are indicated. A scheme is
presented showing the different cell morphologies and cytoskeleton profiles observed.
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fluorescence confocal microscopy, we observed that reference BaL.01 and SF162 Envs,
as well as the chronic progressor Env from patient IV_10_5, induced acetylation of
-tubulin and F-actin capping and pseudopod formation in 44.7, 30.7, and 26.3% of
cells, respectively (Fig. 5B). In contrast, representative Envs from LTNP-EC patient viruses
showed an impaired ability to trigger F-actin reorganization, thereby inducing low
pseudopod formation with capped reorganized actin and acetylated -tubulin cyto-
skeletons in only 14 to 16% of the cells (Fig. 5B). This difference was statistically
significant (P  0.0061).
Analysis of the link between the low CD4 affinity and the poor fusion activity
confirms that the Env from viruses of LTNP-EC patients hardly promoted the acetylation
of -tubulin compared to HIV-1 BaL.01 Env or R5-tropic Envs from chronic progressor
viruses (Fig. 5A). The low stabilization of acetylated -tubulin and the inability to
reorganize F-actin and form pseudopods are consistent with the low CD4 binding,
resulting in limited viral fusion and early infection (29, 30, 33, 34, 41). Similarly, R5-tropic
Envs from LTNP-EC individuals promoted weak cytoskeleton posttransduction modifi-
cation and reorganization and subsequent poor pseudopod formation (Fig. 5B). Con-
sidering that HIV-1 should overcome the cortical actin barrier during the early infection
steps, the accomplishment of this process will predict the susceptibility of CD4 T cells
to infection (32). Altogether, the poor signaling activity of these Envs is consistent with
their low CD4 binding and the limited Env-mediated membrane fusion and early
infection described for the Envs from the LTNP-ECs.
Analysis of the mutations responsible for the viral replicative capacity of a
replicating virus from the cluster. To further characterize the impaired functionality
of the Env from this LTNP cluster, we studied a functional Env isolated from a virus (AS7)
of this cluster. Virus AS7 was derived from a cluster patient showing detectable p24
antigenemia at the sampling time (1989) and for which we do not have the clinical
phenotype due to the lack of follow-up. The AS7 env shared 11 unusual mutations with
the other env genes from the cluster (35), but it also displayed 3 extra mutations in the
V1, C2, and V4 env regions. These mutations differentiated the AS7 env from the cluster
env genes, as shown for the LTNP_1_12 clone (Fig. 6A). We generated in the AS7 env
backbone three mutant viruses reverting the AS7 residue at positions 140 (V1,
AS7_I140T), 279 (C2, AS7_V279A), and 400 (V4, AS7_I400T) to the residues present in
the LTNP_1_12 clone (and in the other cluster viruses). The Envs with the reverting
I140T and V279A mutations showed an infectious activity below the anti-CD4 threshold
and a nearly defective infection (Fig. 6B), whereas the reversing I400T mutation showed
a limited but detectable infection activity (Fig. 6B). These results support the inefficient
signaling and functionality of the env genes of this cluster and their inefficient infec-
tivity.
DISCUSSION
LTNP-ECs are a minor group of patients who, despite being infected for many years,
show natural control of HIV-1 viral replication and lack of clinical progression. Investi-
gation of the host and viral factors and the mechanisms involved in this control is
important for understanding HIV-1 pathogenesis. In this work, we analyzed the contri-
bution of the Env complex to control viral replication and we show that viruses
recovered from a cluster of LTNP-ECs displayed HIV-1 Envs with low CD4 binding, low
signaling, and therefore low fusion and infection activities.
In HIV-1-infected individuals, viral fitness is a major determinant of the clinical
outcome (18). Among viral proteins that determine fitness in vitro but also in vivo, the
Env glycoprotein plays a major role (25), particularly in the phenotypic characteristics
associated with in vivo depletion of CD4 T cells. The Env owes its key role in viral
replication to the biological activity during viral entry into target cells, which in turn
determines viral tropism and cytopathic effects. The function of HIV-1 Env is a complex,
multistage, and highly regulated process with many cellular molecules mobilized by
the Env viral binding to CD4, CXCR4, or CCR5 receptors. These interactions result in the
formation of a fusion pore through which the viral capsid enters the cell (32). The
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efficient pore fusion formation relies on key signals triggered by Env-CD4 interaction
promoting cytoskeleton modifications (29, 30, 32, 33), such as -tubulin acetylation
(33), F-actin severing, and capping reorganization (29, 30). A deficiency in these
HIV-1-Env-mediated signals leads to a defect in the early steps of viral infection and
replication (29–32, 45).
FIG 6 Analysis of the expression and viral entry efficiency of the different HIV-1-Env proteins from LTNP-EC and control patients. (A) Gp120 partial
amino acid sequences of AS7 virus and the mutants derived in this AS7 virus backbone (AS7_I140T, AS7_V279A, and AS7_I400T) are shown and
compared to the LTNP_1 clone 12 gp120 amino acid sequence from one of the cluster viruses. (B) Luciferase-based assay of viral entry and
infection in permissive CEM.NKR-CCR5 cells by nonreplicative HIV-1 luciferase reporter pseudoviruses bearing viral AS7 Env and the AS7 mutants
shown in panel A and the control BaL.01 Env strain (light gray bars). Nonproductive infection values (baseline) are obtained with a neutralizing
anti-CD4 MAb (5 g/ml), under the same experimental conditions. The quality of viral production and the specificity of CD4 for neutralizing HIV-1
early infection are indicated by the data obtained by using HIV-1 pseudovirus bearing the VSV-G Env. Data are values from 6 independent
experiments carried out in triplicate. a.u., arbitrary light units.
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Pseudoviruses bearing Envs from this cluster of LTNP-EC patients were inefficient in
performing the initial steps of HIV-1 infection, pointing at a potential mechanism to
explain the clinical phenotype. In fact, low viral fusion, infection, and replication
activities were not the consequence of a lower cell surface expression of the Envs, the
levels of which were similar in both groups (Fig. 2A), but were linked to a lower ability
to bind to CD4 in a cell-to-cell HIV-1 transfer assay (Fig. 3E). We observed that the Envs
from LTNP-EC viruses showed a low ability to bind to the cell-surface-expressed CD4 in
primary cells and that the extent of binding correlated to their fusion capacity (P 
0.0171, Spearman’s test) (Fig. 4B). Considering the chronology of CD4 binding and
membrane fusion during HIV-1 entry, this significant correlation provides a causal link
between both observations. Therefore, in this LTNP-EC cluster, the reduced Env-
mediated fusion efficiency is related to the low ability to interact with the cell-surface-
expressed CD4.
The invasion and infection of CD4 T lymphocytes by HIV-1 is a complex process
involving many cellular events triggered after the first Env-CD4 interaction that have
been the subject of many studies (29, 30, 33, 41). The accumulated evidence indicates
that the actin mobilization that occurs before the formation of the fusion pore plays a
central role in this process (29, 30, 32). In fact, the actin cytoskeleton is deeply involved
in the capping of cell surface receptors for viral infection, which facilitates the inter-
action with the Env complex and the subsequent fusion pore formation, entry, and
infection. These HIV-1 Env-gp120/CD4-mediated actin and receptor reorganization and
capping events have been shown to correlate with the infectivity of the virus (29, 30,
32). Moreover, the Env-mediated membrane fusion activity relies directly on the
stabilization of a cortex of acetylated -tubulin, triggered by the first Env-CD4 inter-
action (33, 34). These two key Env-CD4 signals for HIV-1 fusion, entry, and infection
have been a central issue in the present study, where we observed that primary Envs
from viruses of the LTNP-EC cluster individuals present nonefficient Envs for the
promotion of both cortical F-actin reorganization and capping, with neither signal
stabilizing acetylated -tubulin. These data correlated well with the fact that these Envs
are not able to bind CD4 with high affinity. Altogether these data suggest that the low
fusion, infection, and replication activities of viruses from this LTNP-EC cluster are due
to the inability of the viral Envs to bind to CD4 and to subsequently signal to
appropriately rearrange the cortical cytoskeleton to fuse, enter, and infect target cells.
This study supports the role of viral characteristics in the clinical outcome of
LTNP-EC individuals. We observed that the genotypic and phenotypic characteristics of
the Env proteins from HIV-1 viruses of the cluster of LTNP-ECs were inherited by all the
patients’ viruses, which all displayed a low replication capacity and produced, in
individuals with different host genotypes (Table 1), the same clinical LTNP-EC pheno-
type. It is reasonable to assume that because of their poor replicative capacity, these
viruses established a low-level primary infection. The low replicative capacity could also
affect the transmissibility of these viruses; however, the intravenous route of transmis-
sion reported in this cluster could have contributed to overcoming this barrier (Table 1).
The impaired Env functionality favored early immune control of the virus by a strong
immunologic response during not only acute but also chronic HIV-1 infection, deter-
mining the long-term outcome (18, 20). The Envs from the cluster viruses showed low
binding to CD4 and, in parallel, a low signaling activity to modify and reorganize
tubulin and actin cytoskeletons, leading to a low fusion activity. These viral character-
istics outline for the first time a mechanism that directly involves viral Env-associated
functions as being responsible for inefficient performance of the initial steps of the
HIV-1 viral cycle, thereby explaining the poor transmissibility and pathogenicity of the
viruses from the LTNP-EC cluster under investigation. Our results together with those
from a previous work that reported inefficient infection of viruses from LTNP-ECs (11)
could indicate that the ability of HIV-1 to establish efficient infection determines the in
vivo progression of the infection, and as we specifically described here, inefficient
Env-mediated functions appear to be responsible for the LTNP-EC phenotype in this
cluster of HIV-1 individuals.
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Until now, the heritability of HIV-1 virulence has been deduced from transmission
pairs or from phylogenetic inferences in large cohorts of viruses in different countries
and risk group patients, with widely varying results ranging from 7 to 53% of inheri-
tance (16). In this work, we show that the characteristics of the cluster viral Envs have
been inherited by all the viruses from a phylogenetic cluster, even if these patients
showed different host markers, as shown by the HLAs (Table 1). We also demonstrated
that the viral characteristics influence the clinical phenotype of the infected patients.
The heritability of the inefficient functionality of the viral env was observed for the first
time in viruses from a cluster of patients with the same clinical characteristics and
resulted in the same specific nonevolving clinical phenotype. The virus from patient
AS7, whose clinical outcome is unknown, shared 11 mutations with the other cluster
viruses (35), but it presented three extra mutations that we showed were responsible
for the replication capacity of this virus (Fig. 6A and B). These inefficient viral env genes
of the cluster viruses could be very interesting reagents with which to study new
approaches in vaccination programs.
In summary, we have demonstrated for the first time that the low CD4 binding and
signaling characteristics of HIV-1 Envs explain the low replication capacity and trans-
missibility of these viruses. These viral characteristics, particularly in the env genes,
could be the basis for the lack of clinical progression and the LTNP-EC clinical pheno-
type in the cluster of HIV-1 individuals studied in this work. These results demonstrate
not only the important role of HIV-1 viral properties in the clinical characteristics of the
patients, but also, because they were inherited by all viruses in the LTNP-EC cluster, the
heritability of viral properties.
MATERIALS AND METHODS
Samples studied, env nucleotide sequencing, and phylogenetic analysis. Briefly, 184 env nucle-
otide sequences were analyzed, of which 114 were from samples taken before 1995 from Spanish and
North American individuals. The remaining sample sequences (n  70) were obtained from Spanish
LTNPs and other viremic patients infected after 2000 (35). Within these samples, we identified a very tight
and close cluster of viruses, which was not the result of contamination because the nucleotide sequences
were obtained with extreme physical separation measures, in different samples of the patients, and even
in different laboratories (35). The analysis and phylogenetic reconstruction of the tree where the viral
cluster was identified were previously described (35). Five of the cluster subjects were identified as
LTNP-ECs; they were intravenous drug user (IDUs) in the early 1980s, and all lived in Madrid and had a
first HIV-1 serology result between 1985 and 1990. The follow-up of patients LTNP_RF_15 and
LTNP_RF_21 was not performed in our laboratory, and the only clone studied from patient LTNP_RF_21
was kindly provided by R. Delgado (Hospital Doce de Octubre, Madrid, Spain). Epidemiological and
clinical characteristics of patient’s samples are shown in Table 1.
Ethics statement. Samples were obtained from participants in previous studies who gave informed
consent for genetic analysis studies, and they were registered as a sample collection in the Spanish
National Registry of Biobanks for Biomedical Research under no. C.0004030. Consents were approved by
the Ethical and Investigation Committees of the Centro Sanitario Sandoval (Madrid) and Hospital 12 de
Octubre (Madrid), and the samples were encoded and deidentified in these centers. All clinical investi-
gations were conducted according to the principles expressed in the Declaration of Helsinki. The studies
were approved by the Comité de Ética de la Investigación y de Bienestar Animal of the Instituto de Salud
Carlos III under no. CEI PI 05_2010-v3 and CEI PI 09-2013.
Generation of env gene expression plasmids. Several expression plasmids were generated from
env genes of 4 cluster individuals (LTNP_1, LTNP_3, LTNP_RF_21, and AS7), 4 HIV-1 chronic progressors
(I_10, IV_10, I_14, and RIS_06), and 3 laboratory-adapted viruses (SF162, NL4.3, and 89ES_061). The
R5-tropic BaL.01-env (catalog no. 11445) glycoprotein plasmid was from the NIH AIDS Research and
Reference Reagent Program. The env genes were amplified by nested PCR from proviral DNA (35). The
products were cloned into the pcDNA3.1D/V5-His Topo expression vector (Invitrogen). In total, 9 clones
derived from the 4 cluster patients (LTNP_1 clones 8, 10, 12, and 37; LTNP_3 clones 20, 22 and 3; LTNP_RF
clone 21; and AS7), 6 clones from chronic progressors (I_10 clones 27 and 28, IV_10 clones 5 and 16,
RIS_06 clone 2, and patient I_14 clone 9), and 4 clones from reference samples (SF162, 89ES_061, NL4.3,
and BaL.01) were constructed. pcDNA3 plasmids coding for NL4.3-derived mutants D368R and 41.2,
which abrogate CD4 binding and gp41-mediated membrane fusion, respectively, were generated by
site-directed mutagenesis or by subcloning from original plasmids, as previously described (24). Expres-
sion plasmids were transformed in DH5 cells, and clones were sequenced to check the correct insertion
of the env gene.
Cells. The human CEM.NKR-CCR5 permissive cell line (catalog no. 4376), the HEK-293T line (catalog
no. 103), and the TZM-bl line (catalog no. 8129) were from the NIH AIDS Research and Reference Reagent
Program. Cells were cultured and used as previously described (29, 30, 33, 41).
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Functional analysis of cloned Envs. The Env expression plasmids were used to transfect 293T cells
with the CalPhos mammalian transfection kit (Clontech, Palo Alto, CA) in combination with either a Tat
expression plasmid, pTat, for Env expression and fusion assays or with the env-defective HIV-1 backbone
PSG3 plasmid for viral transfer assays (10). Env expression, viral transfer, and fusion capacities were
assessed 24 h after cotransfection by harvesting transfected cells with Versene and washing cell
suspensions twice in phosphate-buffered saline (PBS).
Analysis of cell-surface Env expression. 293T cells were cotransfected with the env expression
plasmids and the tat expression plasmid; 105 cells were incubated with the anti-gp120 antibody 2G12
(4 g/ml; Polymun, Vienna, Austria) for 40 min at 37°C, washed in PBS, and further incubated with
phycoerythrin (PE)-labeled goat anti-human IgG (Jackson ImmunoResearch Laboratories, West Grove, PA)
at room temperature for 15 min. Cells were washed with PBS and acquired in a fluorescence-activated
cell sorter (FACS) LSRII flow cytometer. Data were analyzed using FlowJo software (Tree Star, Inc., San
Carlos, CA). The percentage of Env-expressing cells was used to assess Env expression (10).
Fusion activity. To test the fusion capacity of the Env proteins, 293T cells were cotransfected with
the env expression plasmids and the control tat plasmid. A total of 104 cells were mixed at a 1:1 ratio in
96-well plates with CD4 CXCR4 CCR5 TZM-bl cells for 6 h. 293T cells transfected only with tat plasmid
were used as control. Luciferase activity was measured in a Fluoroskan Ascent (Thermo Fisher Scientific
Oy, Vantaa, Finland) using the Brite-Lite luciferase luminescence assay (PerkinElmer, Akron, OH). The
percentage of Env-expressing cells and the mean fluorescence intensity (MFI) of these cells were used to
calculate relative fluorescence intensity (RFI) as a measure of the number of cell-surface Env molecules
as described previously (46): RFI  % of Env cells  MFI of Env cells The ratio of total fusion to RFI
was considered the fusogenicity index (FI), which estimates the fusogenic capacity of an individual Env
irrespective of the level of expression (10).
Viral transfer activity. To test viral transfer activity, which exclusively depends on the binding of
gp120 to the CD4 molecule, env expression plasmids were cotransfected with the defective pSG3
plasmid in 293T cells. A total of 105 cells were mixed at a 1:1 ratio in 96-well plates with primary CD4
T cells freshly isolated from donors by negative selection (CD4 T cell isolation kit II, human; Miltenyi
Biotec, Inc., Bergisch Gladbach, Germany). Viral transfer was assessed after 2 h of incubation, staining cells
with the anti-HIV-1 p24 antibody Kc57 (Coulter clone; Beckman Coulter, Inc., Brea, CA) (42). Cells were
acquired in a FACS LSRII flow cytometer, and the content of p24 in gated CD4 T cells and gated 293T
cells was analyzed using FlowJo software (Tree Star, Inc.) and expressed as the percentage of p24-positive
cells. The percentage of p24 293T cells was used as a control of transfection efficiency, and the
percentages were similar among experiments. The frequency of p24 CD4 T cells was a direct measure
of the amount of the viruses bound to and taken up by these cells.
Production of viral particles with luciferase reporter pseudoviruses. Replication-deficient lu-
ciferase HIV-1 viral particles (luciferase reporter pseudoviruses) were obtained as described previously
(29, 41, 47), using the luciferase-expressing reporter virus HIV/Δnef/Δenv/luc (pNL4-3.Luc.R-E provirus
bearing the luciferase gene inserted into the nef open reading frame [ORF] and which does not express
env; catalog no. 6070013, NIH AIDS Reagent Program) and the described env expression plasmids from
the different HIV-1 individuals or the reference env plasmids studied. As a control for non-CD4 entry and
infection and viral production, when indicated, cotransduction of the pNL4-3.Luc.R-E provirus (20 g)
vector with the pHEF-VSV-G vector (10 g; NIH AIDS Reagent Program) was used to generate nonrep-
licative viral particles that fuse with cells in a vesicular stomatitis virus glycoprotein (VSV-G)-dependent
manner (41). Viral stocks were normalized by p24-Gag content measured by enzyme-linked immunosor-
bent assay (ELISA [Innotest HIV antigen MAb, reference no. 80563; Fujirebio Europe, Göteborg, Sweden]).
Luciferase viral entry and infection assay. CEM.NKR-CCR5 cells (9  105 cells in 24-well plates with
20 g/ml Polybrene) were infected with 500 ng of p24 of luciferase reporter pseudoviruses in 1 ml total
volume with RPMI 1640 for 2 h (by centrifugation at 1,200  g at 25°C) and subsequent incubation for
4 h at 37°C, as previously described (29, 41, 47). Unbound virus was then removed by washing the
infected cells. After 48 h of infection, luciferase activity was measured using a luciferase assay kit (Biotium,
Hayward, CA) with a microplate reader (Victor X5; PerkinElmer, Waltham, MA). When indicated, permis-
sive cells were pretreated with an anti-CD4 neutralizing MAb (5 g/ml; EBioscience, San Diego, CA).
In vitro mutagenesis. Mutant AS7 clones (AS7_I140T, AS7_V279A, and AS7_I400T) were obtained by
site-directed mutagenesis using the QuikChange site-directed mutagenesis kit (Stratagene) by following
the manufacturer’s instructions. Mutations were verified by DNA sequencing of the ENV-coding region.
Signaling activity assays. (i) Western blot analysis of HIV-1 Env-mediated -tubulin acetylation was
studied in CEM.NKR-CCR5 cells (1  106 cells) incubated with 500 ng of p24 of luciferase reporter
pseudoviruses for 1 h at 37°C (33). Membranes were probed with the anti--tubulin B-5-1-2 monoclonal
antibody (MAb) and the anti-acetylated -tubulin 6-11B-1 MAb (both from Sigma-Aldrich, St. Louis, MO)
and secondary antibodies conjugated with horseradish peroxidase (HRP) (Dako, Glostrup, Denmark). The
increase in -tubulin acetylation was quantified and expressed as the ratio of the intensities of the
acetylated -tubulin to the total -tubulin bands, as described previously (33, 48). (ii) Immunofluores-
cence of HIV-1 Env-mediated acetylated -tubulin and the F-actin capping assay was analyzed in
CEM.NKR-CCR5 cells (1  106 cells/point) incubated with HIV-1 luciferase reporter pseudoviruses (29, 30,
33), as described for Western blot analysis. Coverslips were mounted in Mowiol antifade (Dako) and
imaged in xy midsections in a FluoView FV1000 confocal microscope through a 1.35 NA objective (60)
(Olympus, Center Valley, PA) for high-resolution imaging of fixed treated cells. The final images and
molecule codistributions were analyzed and quantified with MetaMorph software (Universal Imaging,
Downington, PA).
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Statistical analysis. Data and statistical analyses were performed using GraphPad Prism, version 6.07
(GraphPad Software, Inc.). Significance when comparing 2 groups was determined with a 2-tailed
nonparametric Mann-Whitney U test or by nonparametric Dunn’s test for multiple comparisons. Stu-
dent’s t test was used for the comparison of the signaling activity. A nonparametric Spearman’s test was
used to calculate correlations.
Data availability. Data presented have been generated by the three laboratories. Any researcher
will be able to access primary data upon request to jblanco@irsicaixa.es, avalenzu@ull.edu.es, or
clopez@isciii.es.
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